1 not yet recruiting, 1 recruiting. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Not yet recruiting 1, Recruiting 1 |
Follow Memory Loss: new trials by email Literature Review of Memory Loss trials Research Report on Memory Loss
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cholinergic Enhancement of Theta COBENFY KarXT (50/20 mg), Control - Epilepsy, Seizures | Early Phase 1 | Not yet recruiting | University of Texas Southwestern Medical Center | 50 | 2026-12-01 | 2026-09-29 |
| Pharmacological Modulation of Brain Oscillations in Memory Processing Scopolamine (0.4mg), Placebo - Epilepsy, Seizures | Early Phase 1 | Recruiting | University of Texas Southwestern Medical Center | 60 | 2019-08-01 | 2026-10-05 |
Cognitive Dysfunction (2) · Epilepsy (2) · Memory Disorders (2) · Seizures (2)
Brain Diseases (2) · Central Nervous System Diseases (2) · Cognition Disorders (2) · Mental Disorders (2) · Nervous System Diseases (2) · Neurobehavioral Manifestations (2) · Neurocognitive Disorders (2) · Neurologic Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2)
Scopolamine (1)
University of Texas Southwestern Medical Center (2)
United States (2)
R01NS125250 (1)